Waters Corporation has co-led a round that took bioanalytical technology producer Redshift Bioanalytics' total funding to $35m since 2005.
Redshift Bioanalytics, a US-based developer of bioanalytical tools for the life sciences industry, has completed an $11m series C round co-led by laboratory equipment producer Waters Corporation.
The round was co-led by venture capital firm Technology Venture Partners and increased Redshift’s overall funding to approximately $35m, according to regulatory filings.
Founded in 2005, Redshift produces tools like lasers, microfluidics and analytical technology that help protein scientists and drug developers create protein-based drug treatments. It will invest the cash in commercialising…
